CZG LAB
Contact Us

Tel:008613815056465

Fax:0086-0519-86474295

Mobile phone:0086-18861115105

ADD:HongKong Central Stanley Street

Email:info@czgeneral.com

Home  >  News  >  The clinical efficacy of orlistat
The clinical efficacy of orlistat
Thursday 06th July 2017

Orlistat is non-systemic effects of diet pills, can reduce about 30% of total dietary fat intake. According to a summary analysis of multiple clinical studies, orlistat reduce average 2.9kg more weight than placebo, and were 21% and 12% of patients with weight decreased by 5% and 10%. After the diabetic patients taking orlistat, minus the placebo effect is a net weight loss of 2.3kg weight. Orlistat can reduce the incidence of type 2 diabetes, improve cardiovascular risk factors. Compared with placebo, although there was no significant difference in the concentration of triglycerides and Framingham cardiovascular risk score in patients with diabetes, but orlistat diabetes significantly reduced waist circumference, body mass index, systolic blood pressure, diastolic blood pressure, fasting blood glucose, hemoglobin A1C, total cholesterol, LDL cholesterol and HDL cholesterol concentrations.